Core Laboratories (CLB) Expected to Announce Quarterly Earnings on Wednesday

Core Laboratories (NYSE:CLB - Get Free Report) is expected to announce its Q2 2025 earnings results after the market closes on Wednesday, July 23rd. Analysts expect the company to announce earnings of $0.18 per share and revenue of $129.19 million for the quarter. Core Laboratories has set its Q2 2025 guidance at 0.170-0.210 EPS.

Core Laboratories (NYSE:CLB - Get Free Report) last issued its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.15 by ($0.01). Core Laboratories had a return on equity of 15.06% and a net margin of 5.41%. The business had revenue of $123.59 million for the quarter, compared to analyst estimates of $125.09 million. During the same period in the prior year, the company posted $0.19 EPS. The firm's revenue for the quarter was down 4.7% compared to the same quarter last year. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Stock Down 2.9%

Shares of NYSE CLB traded down $0.33 during midday trading on Wednesday, hitting $11.35. The company's stock had a trading volume of 313,780 shares, compared to its average volume of 411,372. The company has a debt-to-equity ratio of 0.48, a current ratio of 2.21 and a quick ratio of 1.64. The firm has a market capitalization of $531.95 million, a price-to-earnings ratio of 19.23, a price-to-earnings-growth ratio of 3.83 and a beta of 1.41. The business's fifty day simple moving average is $11.82 and its two-hundred day simple moving average is $14.20. Core Laboratories has a 1 year low of $10.14 and a 1 year high of $25.13.

Core Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Monday, May 5th were issued a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, May 5th. This represents a $0.04 dividend on an annualized basis and a yield of 0.35%. Core Laboratories's dividend payout ratio (DPR) is presently 6.78%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on CLB shares. Wall Street Zen downgraded shares of Core Laboratories from a "hold" rating to a "sell" rating in a research note on Friday, April 25th. Stifel Nicolaus lowered their target price on Core Laboratories from $13.00 to $12.00 and set a "hold" rating for the company in a research note on Wednesday. Finally, Citigroup cut their price target on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating on the stock in a report on Tuesday, May 13th.

Institutional Inflows and Outflows

A hedge fund recently raised its stake in Core Laboratories stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in Core Laboratories Inc. (NYSE:CLB - Free Report) by 4.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 27,893 shares of the oil and gas company's stock after purchasing an additional 1,170 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned approximately 0.06% of Core Laboratories worth $418,000 at the end of the most recent reporting period. 97.81% of the stock is owned by institutional investors.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.